Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye Syndrome

In brief

The purpose of this study is to assess the safety and efficacy of iontophoretic delivery of dexamethasone phosphate ophthalmic solution using the EyeGate® II Drug Delivery System in patients with dry eye.

Key facts

Study ID

NCT00765804

Run by

Eyegate Pharmaceuticals, Inc.

People needed

89

Starts

2008-10-01

Expected to finish

2009-02-01

Last updated by the study team

2010-08-31

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a reported history of dry eye in each eye
• Be at least 12 years of age
• Demonstrate a response when exposed to the Controlled Adverse Environment model

You may not qualify if…

• Have contraindications to the use of the test articles
• Have known allergy or sensitivity to the study medication or their components (including corticosteroids)
• Have any ocular infections, active ocular inflammation or preauricular lymphadenopathy
• Be current contact lens wearers or wear contacts during the study

Where it is running

• Ophthalmic Research Associates — Andover, Massachusetts, United States
• Ophthalmic Research Associates — North Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.